SHPH Shuttle Pharmaceuticals Holdings Inc
Price (delayed)
$0.419
Market cap
$1.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.19
Enterprise value
$961,410
Highlights
Shuttle Pharmaceuticals Holdings's EPS has increased by 24% from the previous quarter and by 10% YoY
Shuttle Pharmaceuticals Holdings's equity has surged by 154% QoQ but it has shrunk by 83% YoY
The debt has soared by 108% QoQ and by 8% YoY
The company's quick ratio has shrunk by 76% YoY
Key stats
What are the main financial stats of SHPH
Market
Valuations
Earnings
Shares outstanding
4.08M
Market cap
$1.71M
Enterprise value
$961,410
Price to earnings (P/E)
N/A
Price to book (P/B)
2.17
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$7.7M
Net income
-$9.14M
EBIT
-$7.94M
EBITDA
-$7.93M
Free cash flow
-$7.33M
Per share
Balance sheet
Liquidity
EPS
-$3.19
EPS diluted
-$3.3
Free cash flow per share
-$2.55
Book value per share
$0.19
Revenue per share
$0
TBVPS
$0.87
Total assets
$2.51M
Total liabilities
$1.8M
Debt
$1.17M
Equity
$709,152
Working capital
$677,148
Debt to equity
1.65
Current ratio
1.44
Quick ratio
1.25
Net debt/EBITDA
0.09
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-340.4%
Return on equity
-1,237.2%
Return on invested capital
-677.5%
Return on capital employed
-816.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SHPH stock price
How has the Shuttle Pharmaceuticals Holdings stock price performed over time
Intraday
2.77%
1 week
3.71%
1 month
-31.18%
1 year
-88.03%
YTD
-51.22%
QTD
7.71%
Financial performance
How have Shuttle Pharmaceuticals Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.7M
Net income
-$9.14M
Gross margin
N/A
Net margin
N/A
The net income has declined by 39% year-on-year
Shuttle Pharmaceuticals Holdings's operating income has decreased by 31% YoY and by 7% QoQ
Growth
What is Shuttle Pharmaceuticals Holdings's growth rate over time
Valuation
What is Shuttle Pharmaceuticals Holdings stock price valuation
P/E
N/A
P/B
2.17
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Shuttle Pharmaceuticals Holdings's EPS has increased by 24% from the previous quarter and by 10% YoY
Shuttle Pharmaceuticals Holdings's equity has surged by 154% QoQ but it has shrunk by 83% YoY
Efficiency
How efficient is Shuttle Pharmaceuticals Holdings business performance
SHPH's return on equity has dropped by 112% since the previous quarter
The company's return on invested capital has shrunk by 79% QoQ
The ROA fell by 31% QoQ
Dividends
What is SHPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SHPH.
Financial health
How did Shuttle Pharmaceuticals Holdings financials performed over time
SHPH's total assets is 39% greater than its total liabilities
The company's quick ratio has shrunk by 76% YoY
Shuttle Pharmaceuticals Holdings's current ratio has shrunk by 73% YoY
The debt is 65% higher than the equity
Shuttle Pharmaceuticals Holdings's equity has surged by 154% QoQ but it has shrunk by 83% YoY
The debt has soared by 108% QoQ and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.